ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. World
  3. Brazil

Brazil : Bovespa Share Prices, Indexes & News

Bovespa Index 127,599.57-0.5%

IBrX 50 21,495.42-0.4%

Dow Jones 39,512.84+0.3%

Brazilian Stock Search

Look up Brazilian Stocks, Markets, News, Forex and more

Usiminas PNA

7.95
-0.05
-0.63%

Bovespa Index

127,599.57
-588.77
-0.46%

IBrX 50

21,495.42
-88.84
-0.41%

Petrobras PN

41.50
-0.17
-0.41%

Vale ON

64.15
-0.36
-0.56%

Bovespa Stock Exchange

Name Price Change %
AMBEV S/A ON12.01-0.33%
BANCO DO BRASIL ON27.64+1.84%
BRADESCO PN13.35-0.74%
BB SEGURIDADE ON33.06+1.35%
BRADESPAR PN20.03-1.23%
BRF S/A ON18.28-3.33%
BRASKEM PNA19-1.45%
B3 SA - Brasil Bolsa Bal... ON10.93-2.50%
CCR ON12.64-0.71%
CIELO ON5.58-0.18%
CEMIG PN10.11-1.65%
CPFL ENERGIA ON32.44-0.70%
COPEL PNB9.12-1.30%
COSAN ON14.27-1.86%
SID NACIONAL ON13.87-0.07%
CYRELA REALT ON20.91-1.92%
ELETROBRAS ON37.88-0.60%
ELETROBRAS PNB42.02-0.59%
EMBRAER ON33.4-1.74%
GAFISA ON4.81-3.99%
GERDAU PN19.22-0.67%
GERDAU MET PN11.11-1.42%
GOL PN1.25+0.81%
HYPERA ON30.07-1.05%
ITAUSA PN10.03+1.01%

Brazilian Real FOREX

More FOREX
Name Price Change
USD BRLUSDBRL5.1568+0.0000
EUR BRLEURBRL5.5541+0.0000
JPY BRLJPYBRL0.0331+0.0000
GBP BRLGBPBRL6.4584+0.0000
AUD BRLAUDBRL3.4065+0.0000
CHF BRLCHFBRL5.6888+0.0000
CAD BRLCADBRL3.7716+0.0000
BRL HKDBRLHKD1.5157+0.0000
NZD BRLNZDBRL3.1063+0.0000
BRL MXNBRLMXN3.2540+0.0000
BRL RUBBRLRUB17.9752+0.0000

Commodities Prices

More Commodities
Name Market Price %
GoldPM2,360.48+0.00%
SilverPM28.18+0.00%
PlatinumCCOM996.60+0.00%
CopperCCOM4.65+0.00%
Brent Crude OilCCOM82.59+0.00%
GasolineCCOM77.93+0.00%
Natural GasCCOM2.37+0.00%

Market News

More Market News

Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating..

Positive data from Phase 1 trial of RBI-4000 vaccine achieve WHO-established surrogate of protection across all dose cohorts Vector improvements demonstrate broad potential of Replicate's srRNA for expanded indications in complex infectious disease and in situ expression of therapeutic proteins SAN DIEGO, May 11, 2024 /PRNewswire/ -- Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range...

05:41Sobha Developers bring to Singapore an Exclusive Dubai Property Showcase
05:09Tafili Galea'i of Lā'ie Wins 2024 World Fireknife Championship
05:00Infocepts Wins "Customer Data Platform of the Year" Award at 2024 Data Breakthrough Awards
03:14Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention
00:48Report on Africa's digital economy, China-Africa cooperation released in Kenya
23:49Venom BlackBook Zero 14 honored with best business laptop award
22:35Global Times: Xi's fruitful Europe visit brings new impetus to ties

Your Recent History

Delayed Upgrade Clock